41 related articles for article (PubMed ID: 9648345)
1. [Membrane receptors and endocrine tumors: expression of vasopressin receptor V1 modulates the pharmacologic phenotype of adrenocortical tumors].
Luton JP; Bertagna X
Bull Acad Natl Med; 1998; 182(2):299-309; discussion 309-10. PubMed ID: 9648345
[TBL] [Abstract][Full Text] [Related]
2. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors.
Arnaldi G; Gasc JM; de Keyzer Y; Raffin-Sanson ML; Perraudin V; Kuhn JM; Raux-Demay MC; Luton JP; Clauser E; Bertagna X
J Clin Endocrinol Metab; 1998 Jun; 83(6):2029-35. PubMed ID: 9626135
[TBL] [Abstract][Full Text] [Related]
3. Vasopressin receptors modulate the pharmacological phenotypes of Cushing's syndrome.
Arnaldi G; de Keyzer Y; Gasc JM; Clauser E; Bertagna X
Endocr Res; 1998; 24(3-4):807-16. PubMed ID: 9888581
[TBL] [Abstract][Full Text] [Related]
4. Aberrant adrenal sensitivity to vasopressin in adrenal tumours associated with subclinical or overt autonomous hypercortisolism: is this explained by an overexpression of vasopressin receptors?
Joubert M; Louiset E; Rego JL; Contesse V; Kong LC; Benhaim A; Mittre H; Lefebvre H; Reznik Y;
Clin Endocrinol (Oxf); 2008 May; 68(5):692-9. PubMed ID: 17980016
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin-responsive adrenocortical tumor in a mild Cushing's syndrome: in vivo and in vitro studies.
Perraudin V; Delarue C; De Keyzer Y; Bertagna X; Kuhn JM; Contesse V; Clauser E; Vaudry H
J Clin Endocrinol Metab; 1995 Sep; 80(9):2661-7. PubMed ID: 7673409
[TBL] [Abstract][Full Text] [Related]
6. Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates.
Louiset E; Contesse V; Groussin L; Cartier D; Duparc C; Perraudin V; Bertherat J; Lefebvre H
J Endocrinol; 2008 Jan; 196(1):1-9. PubMed ID: 18180312
[TBL] [Abstract][Full Text] [Related]
7. A possible association between aldosterone response to vasopressin and circadian change of aldosterone in the patients with aldosterone-producing adenoma.
Suzuki S; Uchida D; Koide H; Suyama K; Shibata T; Yoshida T; Tanaka T; Noguchi Y; Saito Y; Tatsuno I
Peptides; 2008 Dec; 29(12):2225-31. PubMed ID: 18838094
[TBL] [Abstract][Full Text] [Related]
8. Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol.
Louiset E; Isvi K; Gasc JM; Duparc C; Cauliez B; Laquerrière A; Kuhn JM; Lefebvre H
Endocr Relat Cancer; 2008 Dec; 15(4):1025-34. PubMed ID: 18708508
[TBL] [Abstract][Full Text] [Related]
9. Adrenocorticotropic hormone-independent Cushing's syndrome.
Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443
[TBL] [Abstract][Full Text] [Related]
10. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
Reznik Y; Lefebvre H; Rohmer V; Charbonnel B; Tabarin A; Rodien P; Lecomte P; Bardet S; Coffin C; Mahoudeau J;
Clin Endocrinol (Oxf); 2004 Sep; 61(3):311-9. PubMed ID: 15355446
[TBL] [Abstract][Full Text] [Related]
11. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
[TBL] [Abstract][Full Text] [Related]
12. Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-AIMAH): clinical studies of three kindreds.
Gagliardi L; Hotu C; Casey G; Braund WJ; Ling KH; Dodd T; Manavis J; Devitt PG; Cutfield R; Rudzki Z; Scott HS; Torpy DJ
Clin Endocrinol (Oxf); 2009 Jun; 70(6):883-91. PubMed ID: 19018784
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal gland.
Ueberberg B; Unger N; Sheu SY; Walz MK; Schmid KW; Saeger W; Mann K; Petersenn S
Horm Metab Res; 2008 Mar; 40(3):181-8. PubMed ID: 18246525
[TBL] [Abstract][Full Text] [Related]
14. Arginin-vasopressin regulates proliferative activity of the regenerating rat adrenal cortex.
Trejter M; Carraro G; Rucinski M; Hochol A; Rebuffat P; Nussdorfer GG; Malendowicz LK
Int J Mol Med; 2005 Jun; 15(6):993-7. PubMed ID: 15870905
[TBL] [Abstract][Full Text] [Related]
15. Hyper-responsiveness of adrenal gland to vasopressin resulting in enhanced plasma cortisol in patients with adrenal nodule(s).
Suzuki S; Uchida D; Koide H; Tanaka T; Noguchi Y; Saito Y; Tatsuno I
Peptides; 2008 Oct; 29(10):1767-72. PubMed ID: 18620013
[TBL] [Abstract][Full Text] [Related]
16. Ectopic expression of the pituitary V3 vasopressin receptor reveals new aspects of the ectopic ACTH syndrome.
Bertherat J
Eur J Endocrinol; 1996 Aug; 135(2):173-4. PubMed ID: 8810728
[No Abstract] [Full Text] [Related]
17. [Chemotherapy of adrenal cortex tumors (preparation DDD)].
Minenkova EA; Vermel' EM
Vopr Onkol; 1965; 11(10):106-13. PubMed ID: 5333875
[No Abstract] [Full Text] [Related]
18. Endocrine tumors: molecular biology at the bedside?
Macdonald JS
Curr Opin Oncol; 1994 Jan; 6(1):51-2. PubMed ID: 8204691
[No Abstract] [Full Text] [Related]
19. [Vasopressin receptors].
Mori T; Nakamura S; Fujiki H
Nihon Yakurigaku Zasshi; 2006 Aug; 128(2):110-2. PubMed ID: 16998986
[No Abstract] [Full Text] [Related]
20. [Role of vasopressin receptor in psychological and cognitive functions].
Egashira N; Mishima K; Iwasaki K; Nakanishi H; Oishi R; Fujiwara M
Nihon Yakurigaku Zasshi; 2009 Jul; 134(1):3-7. PubMed ID: 19602779
[No Abstract] [Full Text] [Related]
[Next] [New Search]
